Phase II study of continuous infusion recombinant gamma interferon in renal carcinoma. A Southwest Oncology Group study.
Kuebler
J P
JP
University of Oklahoma Health Sciences Center.
Goodman
P J
PJ
Brown
T D
TD
Crawford
E D
ED
Reitz
C L
CL
Knight
W A
WA
Kish
J A
JA
D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007371:Interferon-gamma / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins
D011994:Recombinant Proteins; D007371:Interferon-gamma